Guardant Health Inc (GH)
16.07
-0.62
(-3.71%)
USD |
NASDAQ |
Apr 19, 16:00
16.07
0.00 (0.00%)
After-Hours: 17:56
Guardant Health Cash from Operations (TTM): -324.98M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -324.98M |
September 30, 2023 | -337.00M |
June 30, 2023 | -337.36M |
March 31, 2023 | -355.28M |
December 31, 2022 | -309.46M |
September 30, 2022 | -295.70M |
June 30, 2022 | -270.69M |
March 31, 2022 | -221.34M |
December 31, 2021 | -209.02M |
September 30, 2021 | -191.25M |
June 30, 2021 | -146.16M |
Date | Value |
---|---|
March 31, 2021 | -106.94M |
December 31, 2020 | -103.93M |
September 30, 2020 | -75.05M |
June 30, 2020 | -65.64M |
March 31, 2020 | -56.11M |
December 31, 2019 | -47.13M |
September 30, 2019 | -43.33M |
June 30, 2019 | -66.72M |
March 31, 2019 | -69.93M |
December 31, 2018 | -72.18M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-355.28M
Minimum
Mar 2023
-43.33M
Maximum
Sep 2019
-187.53M
Average
-191.25M
Median
Sep 2021
Cash from Operations (TTM) Benchmarks
Exact Sciences Corp | 156.12M |
Illumina Inc | 478.00M |
Delcath Systems Inc | -31.25M |
CytoSorbents Corp | -21.66M |
Progyny Inc | 188.81M |